Joint Stock (NASDAQ:JYNT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$9.26

52W Range

$7.50 - $11.78

50D Avg

$8.83

200D Avg

$8.83

Market Cap

$127.59M

Avg Vol (3M)

$109.08K

Beta

1.09

Div Yield

-

JYNT Company Profile


The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners. As of March 1, 2022, the company maintained approximately 700 active locations throughout the United States. Founded in 2010, The Joint Corp. maintains its primary corporate headquarters in Scottsdale, Arizona.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

330

IPO Date

Nov 11, 2014

Website

JYNT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Product and Service, Other$1.83M$1.89M$1.53M
Advertising$10.45M$9.18M$8.32M
Franchise$3.37M$3.00M$2.88M
Technology Service$6.04M$5.69M$5.09M
Royalty$33.20M$32.14M$29.16M
Revenues and Management Fees from Company Clinics--$70.72M

Fiscal year ends in Dec 25 | Currency in USD

JYNT Financial Summary


Dec 25Dec 24Dec 23
Revenue$54.90M$52.16M$46.98M
Operating Income$187.20K$-1.89M$318.30K
Net Income$2.91M$-5.80M$-9.75M
EBITDA$1.90M$2.90M$8.88M
Basic EPS$0.19$-0.57$-0.66
Diluted EPS$0.19$-0.56$-0.66

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 11, 26 | 12:00 AM
Q4 25Mar 12, 26 | 5:00 PM
Q3 25Nov 07, 25 | 5:00 PM

Peer Comparison


TickerCompany
BTMDbiote Corp.
CCLDCareCloud, Inc.
DCGODocGo Inc.
IKTInhibikase Therapeutics, Inc.
RPIDRapid Micro Biosystems, Inc.
APYXApyx Medical Corporation
CGTXCognition Therapeutics, Inc.
SERASera Prognostics, Inc.
LUCDLucid Diagnostics Inc.